3.94600 EUR
0.036
0.92%
Last update Dec 17, 7:32 PM CET
Main market
Day range
3.84600
3.94600
Previous close
3.91000
Open
3.84600
Access this stock data via API
Subscribe
Arbutus Biopharma Corporation
3.95
0.04
0.92%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023
Total reported revenue 5.3M 18.1M
Cost of revenue
Gross profit
Operating expense
Research & development 46.1M 73.7M
Selling general and admin 18.8M 22.5M
Other operating expenses
Operating income -59.7M -78.0M
Non operating interest income
Income 5.6M 5.7M
Expense 116.8K 459K
Other income expense -5.5M -44K
Pretax income -59.6M -72.8M
Tax provision 0 0
Net income -59.6M -72.8M
Basic EPS -0.4 -0.4
Diluted EPS -0.4 -0.4
Basic average shares 158.2M 178.4M
Diluted average shares 158.2M 178.4M
EBITDA -52.9M -70.9M
Net income from continuing op. -59.6M -72.8M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 26 minutes

11:33
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).